Sub-theme: Medical devices and equipment
Globus Medical is a best-in-class spinal medical technology company headquartered in Pennsylvania, US. It has a large portfolio of solutions to promote healing in patients with musculoskeletal disorders. A newer, fast growing segment called “Enabling Technologies” centres around ExcelsiusGPS, the world’s first robotic navigation platform which supports surgeons in spinal operations. Globus Medical merged with its direct competitor NuVasive in September 2023. The company was founded in 2003.
Impact Score: 17%
Globus Medical’s musculoskeletal products consist of spinal implants, biologics, accessories, and surgical instruments which are essential for surgical interventions to relieve pain and improve mobility regarding mostly spine-related disorders. The ExcelsiusGPS system improves the accuracy of e.g. screw placements resulting in improved health outcomes and shorter surgery procedures.
Fundamental Quality: 62%
Globus Medical is an innovation-driven company with an established core segment addressing musculoskeletal disorders which creates a steady, dependable, recurring revenue stream complemented by a market-leading product in the nascent robotics space which enjoys strong growth. However, we have identified some ESG- related weaknesses due to a dual-class shareholder structure, poor disclosure and inadequate independence of board committee members.
(per £1m invested in this company FY23)
Forthcoming
- Imaging systems that rely on computed tomography are associated with an increased radiation exposure to the patient
- Medical devices are usually packaged in sterile single-use plastic